44 results
8-K
EX-10.1
AXLA
Axcella Health Inc.
17 Feb 23
Departure of Directors or Certain Officers
5:17pm
8-K
EX-10.2
AXLA
Axcella Health Inc.
17 Feb 23
Departure of Directors or Certain Officers
5:17pm
8-K
EX-10.3
AXLA
Axcella Health Inc.
17 Feb 23
Departure of Directors or Certain Officers
5:17pm
10-Q
2022 Q3
EX-10.2
AXLA
Axcella Health Inc.
Quarterly report
1 Nov 22
4:13pm
8-K
EX-10.1
AXLA
Axcella Health Inc.
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
8-K
EX-10.2
fo21k 8h4sulblab6wn
23 Sep 22
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
zxm8 w7l4cdgwim
23 Sep 22
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
5v4khl 17obsfixb
16 Mar 22
Axcella Therapeutics Announces $25 Million Registered Direct Offering of Common Stock Priced At the Market
8:30am
8-K
EX-10.1
8jg0 5glblkw6a
7 Feb 22
Axcella Therapeutics Announces Appointment of New Chief Financial Officer
4:00pm
8-K
EX-10.1
wp1r bqqba8l8zwr5at7
7 Dec 21
Departure of Directors or Certain Officers
6:15am
8-K
EX-10.1
eyhjkhwjpoh
7 Sep 21
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-10.1
3b7lxixwkd5725n twz6
3 Mar 21
Axcella Announces Alison D. Schecter, M.D., as President of R&D
5:26pm
8-K
EX-10.1
irrf7co5s04n ox9pm5
31 Aug 20
Entry into a Material Definitive Agreement
9:00am